Icagen Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Icagen Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1955
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Icagen Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Icagen Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Icagen Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Icagen Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Icagen Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Icagen Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Icagen Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Icagen Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Icagen Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
PARTNERSHIP 7
Partnership – Overview 7
Partnership – Deal reports 8
CAPITAL RAISING 52
Capital Raising – Overview 52
Capital Raising – Deal reports 53
PRIVATE EQUITY & OWNERSHIP 64
Private Equity and Ownership – Deal reports 64
APPENDIX 69
Contact Us 69
About MarketLine Financial Deals Database 69
Deal Definition and Methodology 71
About MarketLine 78

List of Tables
Table 1: Icagen Inc partnership volume and value trend (2014-YTD2018)
Table 2: Icagen Inc partnership trend by key deal type (2014-YTD2018)
Table 3: Icagen Inc capital raising volume and value trend (2014-YTD2018)
Table 4: Icagen Inc capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Icagen Inc partnership volume and value trend (2014-YTD2018)
Figure 2: Icagen Inc partnership trend by key deal type (2014-YTD2018)
Figure 3: Icagen Inc capital raising volume and value trend (2014-YTD2018)
Figure 4: Icagen Inc capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Icagen Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Piramal Enterprises Ltd (PEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • Warp Drive Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Warp Drive Bio Inc (Warp Drive) is a natural products provider. The company utilizes the proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART platform offers solutions to the pharmaceutical opportunities. Warp Drive's integr …
  • Solar Alliance Energy Inc.:企業のM&A・事業提携・投資動向
    Solar Alliance Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solar Alliance Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Allergan Plc (AGN)-製薬・医療分野:企業M&A・提携分析
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析
    Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic …
  • Suda Ltd (SUD)-製薬・医療分野:企業M&A・提携分析
    Summary Suda Ltd (Suda) is a drug delivery company that offers oro-mucosal administration solutions. The company’s products include artimist, zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its artimist is a sub-lingual spray for the treatment of p. falciparum severe paediatric malaria. S …
  • Nationwide Building Society:企業の戦略・SWOT・財務情報
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ContraVir Pharmaceuticals Inc (CTRV):企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • ConforMIS Inc (CFMS):医療機器:M&Aディール及び事業提携情報
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • CynergisTek, Inc. (CTEK):企業の戦略的SWOT分析
    CynergisTek, Inc. (CTEK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • LRAD Corporation:戦略・SWOT・企業財務分析
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Synopsys, Inc.:企業の戦略・SWOT・財務情報
    Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report Summary Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hino Motors, Ltd.:企業の戦略・SWOT・財務情報
    Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China Sunshine Paper Holdings Company Limited:戦略・SWOT・企業財務分析
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Toshiba America Electronic Components, Inc.:企業の戦略的SWOT分析
    Toshiba America Electronic Components, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Matrix IT Ltd (MTRX):企業の財務・戦略的SWOT分析
    Matrix IT Ltd (MTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Punch Taverns Plc:企業のM&A・事業提携・投資動向
    Punch Taverns Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Punch Taverns Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Coats Group plc:企業の戦略・SWOT・財務情報
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆